Business Standard

Tuesday, December 24, 2024 | 03:10 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Moderna prices Covid vaccine at $32-$37 per dose for smaller volume deals

As the race to develop Covid-19 vaccines reach a decisive stage, with several candidates being tested in pivotal late-stage studies, pricing has come under increasing scrutiny.

moderna
Premium

Moderna, which has no drugs on the market, has received nearly $1 billion from the U.S. government under a plan to speed up vaccine development.

Reuters
Moderna Inc said on Wednesday smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per dose, higher than the price set by the U.S. deal for Pfizer Inc's vaccine candidate.

As the race to develop Covid-19 vaccines reach a decisive stage, with several candidates being tested in pivotal late-stage studies, pricing has come under increasing scrutiny.

"We will be responsible on price well below (its) value during the pandemic," Chief Executive Officer Stephane Bancel said on a conference call, adding that larger volume agreements for its vaccine will be priced lower.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in